Seekwell

Company Overview

Snapshot

Founded in May 2018 by Ron Shimoni, Eden Firuz, and Oded Shoseyov, Seekwell operates with 1-10 employees. The company has raised $4 million across one funding round from BOL (Breath of Life) Pharma. In February 2022, BOL (Breath of Life) Pharma invested in Seekwell.

Business overview

Seekwell, operating in the Health Tech & Life Sciences sector, specializes in cannabis-based therapeutics. The company has developed a technology that matches hemp-based formulations to specific medical and physical indications through pinpoint biochemical analysis and a proprietary AI-assisted process. Seekwell's platform is designed to ensure a stable supply chain for its partners' products, targeting an expanding variety of medical indications within the Pharmaceuticals sector, particularly Medical Cannabis, and serves consumers and patients in the United States.

Strategic signal

In June 2026, Seekwell ceased its operations, indicating a significant strategic shift for the company. This development signals to investors and innovation teams the conclusion of its venture in cannabis-based therapeutics, marking an important inflection point in its corporate trajectory.

Company Intelligence Q&A

When was Seekwell founded and by whom?

Seekwell was founded in May 2018 by Ron Shimoni, Eden Firuz, and Oded Shoseyov.

What is Seekwell's primary focus?

Seekwell focuses on cannabis-based therapeutics, developing technology for matching hemp-based formulations to medical indications using AI-assisted biochemical analysis.

What was a key product launch for Seekwell?

In June 2021, Seekwell launched its first product, Blosm, which is designed for women.

Which company invested in Seekwell?

In February 2022, BOL (Breath of Life) Pharma invested $4 million in Seekwell.

What is the current operational status of Seekwell?

Seekwell ceased to operate in June 2026.